PHIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Phio Pharmaceuticals Corp (PHIO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks clear positive momentum, has bearish technical indicators, and no significant trading signals. While the company has improved its cash position and beat earnings expectations, its financial performance remains weak, and the stock is expected to decline in the short term. A wait-and-watch approach is recommended.
The technical indicators for PHIO are bearish. The MACD is below zero and negatively contracting, RSI is neutral at 58.272, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level of 1.18 in pre-market, with support at 0.998. Overall, there is no clear upward momentum.
Cash and cash equivalents increased significantly from $5.4 million to $21.0 million YoY, providing more resources for R&D investments.
The stock is expected to decline by -2.93% in the next week and -11.99% in the next month based on candlestick pattern analysis. Additionally, the company has no significant trading trends from hedge funds or insiders, and its financials remain weak with negative net income and EPS.
In Q3 2025, the company showed a YoY improvement in net income (-$2.39M, up 56.96%), but EPS dropped significantly (-71.43% YoY). Revenue and gross margin remained at 0, indicating no operational revenue generation.
No analyst rating or price target data available.
